The study, which has not yet been reviewed by other scientists, was supported by grants from the US’ National Institutes of Health and the University of Virginia.
Hydroxychloroquine, the “miracle drug" being tested on India’s healthcare workers, alone is unlikely to be as effective at treating the disease as touted but could instead raise the risk of death for the patients, one of the largest studies on it has shown.
The retrospective analysis of data from 368 male patients hospitalized with the disease in all US Veterans Health Administration medical centres until April 11 showed that out of the risk of death from any cause was higher in the group of patients who were administered only hydroxychloroquine as compared to those who were not